<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mp ids='MP_0002947'>Angiomas</z:mp> are vascular malformations conceived as congenital anomalies </plain></SENT>
<SENT sid="1" pm="."><plain>Surgical excision is the treatment of choice; an alternative is embolization </plain></SENT>
<SENT sid="2" pm="."><plain>Radiation therapy is indicated: (1) for <z:mp ids='MP_0002947'>angiomas</z:mp> in vital or sensitive regions of the brain where they cannot be excised without the risk of a disabling neurological deficit and (2) for residual <z:mp ids='MP_0002947'>angiomas</z:mp> after partial embolization or incomplete surgical removal </plain></SENT>
<SENT sid="3" pm="."><plain>The most effective radiotherapy for <z:mp ids='MP_0002947'>angiomas</z:mp> is radiosurgery. "Radiosurgery" is a term used for a special concept of radiotherapy </plain></SENT>
<SENT sid="4" pm="."><plain>It describes stereotactically guided single high-dose irradiation </plain></SENT>
<SENT sid="5" pm="."><plain>Therefore, a linear accelerator was modified at the German <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> Research Center in Heidelberg </plain></SENT>
<SENT sid="6" pm="."><plain>The precise localization of the target point and a steep dose gradient outside the target volume allow application of high doses to the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> without damage to the surrounding <z:mpath ids='MPATH_458'>normal</z:mpath> brain tissue </plain></SENT>
<SENT sid="7" pm="."><plain>Since 1984, in Heidelberg 41 patients with cerebral <z:mp ids='MP_0002947'>angiomas</z:mp> have been treated by stereotactic single high-dose irradiation (doses: 10-28 Gy) </plain></SENT>
<SENT sid="8" pm="."><plain>Eighteen patients were angiographically examined with a follow-up period longer than 18 months </plain></SENT>
<SENT sid="9" pm="."><plain>In 7 patients, the pathological vessels was completely obliterated and in 6 partially </plain></SENT>
<SENT sid="10" pm="."><plain>There was no change in 6 patients - <z:hpo ids='HP_0000001'>all</z:hpo> of whom received target doses of below 12 Gy </plain></SENT>
</text></document>